Secondary Tumor Patient-Derived Cells
-
+
Specifications
- 1 mln cells/vial
- Post-thaw viability - ≥ 80%
- Culture Type - monolayer or spheroid; adherent or partially adherent
- Passage Number - P1–P5 (low-passage, minimally adapted)
Description
Secondary tumor patient-derived cells (PDCs) are primary tumor cells isolated from metastatic lesions in cancer patients. These cells are cultured directly from solid tumor biopsies or fluid metastases (e.g., ascites, pleural effusion) and retain the molecular, phenotypic, and functional features of the metastatic tumor environment.
